Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Lachner

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Southern Medical Journal|May 4, 2019
Patients on Involuntary Hold Status in the Emergency DepartmentArchana Roy, Christian Lachner, Adrian Dumitrascu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsPaula Aduen, John A Lucas, Christian Lachner, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 14, 2025
Association between visual hallucinations and α-synuclein oligomers in patients with dementia with Lewy bodiesHiroaki Sekiya, Lukas Franke, Daisuke Ono, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 3, 2022
Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brainChristina M Moloney, Sydney A Labuzan, Julia E Crook, et al.
Neurology. Clinical Practice|December 28, 2023
Best Practices for Communicating a Diagnosis of Dementia: Results of a Multi-Stakeholder Modified Delphi Consensus ProcessMelissa J Armstrong, Noheli Bedenfield, Monica Rosselli, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|May 5, 2025
Antiamyloid Monoclonal Antibodies in Alzheimer's Disease, Part 1: Patient SelectionJames R Bateman, Tara C Carlisle, Yanghong Yang, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|June 26, 2025
Antiamyloid Monoclonal Antibodies in Alzheimer's Disease Part 2: Challenges in Dementia Care Delivery System LogisticsTara C Carlisle, James R Bateman, Yanghong Yang, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
The Neurofibrillary Tangle Maturity Scale: A Novel Framework for Tangle Pathology Evaluation in Alzheimer's DiseaseChristina M Moloney, Matthew H Rutledge, Sydney A Labuzan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisChristian Lachner, Sheina Emrani, Lindsey A Kuchenbecker, et al.
Pharmacology Research & Perspectives|January 30, 2019
Frequency and predictors of the potential overprescribing of antidepressants in elderly residents of a geographically defined U.S. populationWilliam V Bobo, Brandon R Grossardt, Maria I Lapid, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Southern Medical Journal|May 4, 2019
Patients on Involuntary Hold Status in the Emergency DepartmentArchana Roy, Christian Lachner, Adrian Dumitrascu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsPaula Aduen, John A Lucas, Christian Lachner, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 14, 2025
Association between visual hallucinations and α-synuclein oligomers in patients with dementia with Lewy bodiesHiroaki Sekiya, Lukas Franke, Daisuke Ono, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 3, 2022
Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brainChristina M Moloney, Sydney A Labuzan, Julia E Crook, et al.
Neurology. Clinical Practice|December 28, 2023
Best Practices for Communicating a Diagnosis of Dementia: Results of a Multi-Stakeholder Modified Delphi Consensus ProcessMelissa J Armstrong, Noheli Bedenfield, Monica Rosselli, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|May 5, 2025
Antiamyloid Monoclonal Antibodies in Alzheimer's Disease, Part 1: Patient SelectionJames R Bateman, Tara C Carlisle, Yanghong Yang, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|June 26, 2025
Antiamyloid Monoclonal Antibodies in Alzheimer's Disease Part 2: Challenges in Dementia Care Delivery System LogisticsTara C Carlisle, James R Bateman, Yanghong Yang, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
The Neurofibrillary Tangle Maturity Scale: A Novel Framework for Tangle Pathology Evaluation in Alzheimer's DiseaseChristina M Moloney, Matthew H Rutledge, Sydney A Labuzan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisChristian Lachner, Sheina Emrani, Lindsey A Kuchenbecker, et al.
Pharmacology Research & Perspectives|January 30, 2019
Frequency and predictors of the potential overprescribing of antidepressants in elderly residents of a geographically defined U.S. populationWilliam V Bobo, Brandon R Grossardt, Maria I Lapid, et al.
Pageof 5